Upregulation in Shh and Patched-1 (receptor and a target gene of Shh signaling) protein levels in CML-variants is evident even here, unlike CML-CP patients (Fig. 1B). This evidence concerns the gene PTCH1 and chronic myelogenous leukemia, BCR-ABL1 positive.